Below are the earnings highlights for Myriad Genetics Inc. (MYGN):
Earnings: -$31.2 million in Q4 vs. -$42.3 million in the same period last year.
EPS: -$0.36 in Q4 vs. -$0.52 in the same period last year.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of $3.5 million or $0.04 per share for the period.
Analysts projected $0.01 per share
Revenue: $196.6 million in Q4 vs. $177.8 million in the same period last year.
For comments and feedback: editorial@rttnews.com